Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 12/2005

01-12-2005 | Original Paper

Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma

Author: Shohei Koyama

Published in: Journal of Cancer Research and Clinical Oncology | Issue 12/2005

Login to get access

Abstract

Purpose:The crucial role of tumor stroma in cancer cell invasion has been described in human carcinoma tissues. However, myofibroblastic invasion remains largely unexplored in malignant ascites. Purpose of this study is to investigate the spatial localization or regulation of matrix metalloproteinases (MMP-2, -7 -9, MT1-MMP) and their inhibitors (TIMP-2 and -4) on myofibroblasts from malignant ascites in 20 patients with gastric carcinoma. Methods: The quantitative flow cytometric analysis of MMPs or TIMPs on myofibroblasts was based on the percentage of double positive cells defined by anti MMPs or anti TIMPs, and anti α-smooth muscle actin (α-SMA) antibodies. Result: The results clearly showed that the coordination of the high level of cell-surface expression of secreted MMPs and TIMPs was noted on the α-SMA+ myofibroblasts. The finding suggests the possible formation of ternary complex, MT1-MMP/TIMPs/MMPs on the cells. The events might be a cause and result of activation processing of MMPs on the cells. Conclusion: This study provides the presence of invasive myofibroblasts with activated MMPs in close association with MMPs+ and TIMPs+ cancer cells and tumor-infiltrating lymphocytes from malignant ascites, emphasizing the importance of molecular cross-talk in tumor-host microenvironment for cancer invasion, metastasis and progression.
Literature
go back to reference Barth PJ, zu Schweinsberg TS, Ramaswamy A, Moll R (2004) CD34+ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 444:231–234CrossRefPubMed Barth PJ, zu Schweinsberg TS, Ramaswamy A, Moll R (2004) CD34+ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 444:231–234CrossRefPubMed
go back to reference Bisson C, Blacher S, Polette M, Blanc J-F, Kebers F, Desreux J, Tetu B, Rosenbaum J, Foidart J-M, Birembaut P, Noel A (2003) Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer 105:7–13CrossRefPubMed Bisson C, Blacher S, Polette M, Blanc J-F, Kebers F, Desreux J, Tetu B, Rosenbaum J, Foidart J-M, Birembaut P, Noel A (2003) Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer 105:7–13CrossRefPubMed
go back to reference Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJT, Muller WJ, Cardiff RD (1998) CD44v (3, 8–10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase 9 (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176:206–215CrossRefPubMed Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJT, Muller WJ, Cardiff RD (1998) CD44v (3, 8–10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase 9 (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176:206–215CrossRefPubMed
go back to reference Brooks PC, Stromblad S, Saunders LC, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85:683–693CrossRefPubMed Brooks PC, Stromblad S, Saunders LC, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85:683–693CrossRefPubMed
go back to reference Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111CrossRefPubMed Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111CrossRefPubMed
go back to reference Fiore E, Fusco C, Romero P, Stamenkovic I (2002) Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21:5213–5223CrossRefPubMed Fiore E, Fusco C, Romero P, Stamenkovic I (2002) Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21:5213–5223CrossRefPubMed
go back to reference Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. (2004) Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64:7045–7049CrossRefPubMed Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. (2004) Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64:7045–7049CrossRefPubMed
go back to reference Heppner KJ, Matrsian LM, Jensen R A, Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:279–282 Heppner KJ, Matrsian LM, Jensen R A, Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:279–282
go back to reference Ishikawa S. Takenaka K, Yanagihara K, Miyahara R, Kawano Y, Otake Y, Hasegawa S, Wada H, Tanaka F (2004) Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. Clin Cancer Res 10:6579–6585CrossRefPubMed Ishikawa S. Takenaka K, Yanagihara K, Miyahara R, Kawano Y, Otake Y, Hasegawa S, Wada H, Tanaka F (2004) Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. Clin Cancer Res 10:6579–6585CrossRefPubMed
go back to reference Koyama S (2000) Apoptotic depletion of infiltrating mucosal lymphocytes associated with Fas ligand expression by Helicobacter pylori-infected gastric mucosal epithelium: Human glandular stomach as a site of immune privilege. Dig Dis Sci 45:773–780CrossRefPubMed Koyama S (2000) Apoptotic depletion of infiltrating mucosal lymphocytes associated with Fas ligand expression by Helicobacter pylori-infected gastric mucosal epithelium: Human glandular stomach as a site of immune privilege. Dig Dis Sci 45:773–780CrossRefPubMed
go back to reference Koyama S (2003a) Flow cytometric measurement of tumor necrosis factor-related apoptosis inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J Gastroenterol Hepatol 18:763–770CrossRef Koyama S (2003a) Flow cytometric measurement of tumor necrosis factor-related apoptosis inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J Gastroenterol Hepatol 18:763–770CrossRef
go back to reference Koyama S (2003b) Differential expression of intracellular apoptotic signaling molecules in tumor and tumor-infiltrating lymphocytes during the development of invasion and/or metastasis of gastric carcinoma. Dig Dis Sci 48:2290–2300CrossRef Koyama S (2003b) Differential expression of intracellular apoptotic signaling molecules in tumor and tumor-infiltrating lymphocytes during the development of invasion and/or metastasis of gastric carcinoma. Dig Dis Sci 48:2290–2300CrossRef
go back to reference Koyama S (2004a) Enhanced cell-surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma. Dig Dis Sci 49:1621–1630CrossRef Koyama S (2004a) Enhanced cell-surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma. Dig Dis Sci 49:1621–1630CrossRef
go back to reference Koyama S (2004b) Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Scand J Gastroenterol 39:1046–1053CrossRef Koyama S (2004b) Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Scand J Gastroenterol 39:1046–1053CrossRef
go back to reference Koyama S, Maruyama T, Adachi S, Nozue M (1998) Expression of costimulatory molecules, B7–1 and B7–2 on human gastric carcinoma. J Cancer Res Clin Oncol 124:383–388CrossRefPubMed Koyama S, Maruyama T, Adachi S, Nozue M (1998) Expression of costimulatory molecules, B7–1 and B7–2 on human gastric carcinoma. J Cancer Res Clin Oncol 124:383–388CrossRefPubMed
go back to reference Koyama S, Maruyama T, Adachi S (1999) Expression of epidermal growth factor receptor and CD44 splicing variants sharing exsons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. J Cancer Res Clin Oncol 125:47–54CrossRefPubMed Koyama S, Maruyama T, Adachi S (1999) Expression of epidermal growth factor receptor and CD44 splicing variants sharing exsons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. J Cancer Res Clin Oncol 125:47–54CrossRefPubMed
go back to reference Koyama S, Koike N, Adachi S (2001) Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape by gastric carcinoma. J Cancer Res Clin Oncol 127:20–26CrossRefPubMed Koyama S, Koike N, Adachi S (2001) Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape by gastric carcinoma. J Cancer Res Clin Oncol 127:20–26CrossRefPubMed
go back to reference Koyama S, Koike N, Adachi S (2002) Expression of TNF-related apoptosis inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 128:73–79CrossRefPubMed Koyama S, Koike N, Adachi S (2002) Expression of TNF-related apoptosis inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 128:73–79CrossRefPubMed
go back to reference Nakayama H, Enzan H, Miyazaki E, Toi M (2002) α Smooth muscle actin positive stromal cells in gastric carcinoma. J Clin Pathol 55:741–744CrossRefPubMed Nakayama H, Enzan H, Miyazaki E, Toi M (2002) α Smooth muscle actin positive stromal cells in gastric carcinoma. J Clin Pathol 55:741–744CrossRefPubMed
go back to reference Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct progression of initiated human prostatic epithelium. Cancer Res 59:5002–5011PubMed Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct progression of initiated human prostatic epithelium. Cancer Res 59:5002–5011PubMed
go back to reference Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi YT, Inoue S, Takahashi M, Hata T, Muramatsu M (2001) Cancer-associated myofibroblast possess various factors to promote endometrial tumor progression. Clin Cancer Res 7:3097–3105PubMed Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi YT, Inoue S, Takahashi M, Hata T, Muramatsu M (2001) Cancer-associated myofibroblast possess various factors to promote endometrial tumor progression. Clin Cancer Res 7:3097–3105PubMed
go back to reference Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L, Stamp GWH (1992) Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389–396PubMed Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L, Stamp GWH (1992) Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389–396PubMed
go back to reference Sappino AP, Schurch W, Gabbiani G (1990) Differentiation repertoire of fibroblastic cell: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144–161PubMed Sappino AP, Schurch W, Gabbiani G (1990) Differentiation repertoire of fibroblastic cell: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144–161PubMed
go back to reference Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G (1986) A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787–2796CrossRefPubMed Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G (1986) A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787–2796CrossRefPubMed
go back to reference Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR (2002) Reactive stroma in human prostate cancer: induction of myofibrblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8:2912–2923PubMed Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR (2002) Reactive stroma in human prostate cancer: induction of myofibrblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8:2912–2923PubMed
go back to reference Yen TWF, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH Jr (2002) Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 131:129–134CrossRefPubMed Yen TWF, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH Jr (2002) Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 131:129–134CrossRefPubMed
go back to reference Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase MMP-9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35–48PubMed Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase MMP-9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35–48PubMed
go back to reference Yu WH, Woessner JF Jr, McNeish JD, Stamenkovic I (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor receptor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16:307–323CrossRefPubMed Yu WH, Woessner JF Jr, McNeish JD, Stamenkovic I (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor receptor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16:307–323CrossRefPubMed
Metadata
Title
Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma
Author
Shohei Koyama
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 12/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-005-0030-3

Other articles of this Issue 12/2005

Journal of Cancer Research and Clinical Oncology 12/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.